| 1 |
34126912 | Novel Benzyloxyphenyl Pyrimidine-5-Carbonitrile Derivatives as Potential Apoptotic Antiproliferative Agents. | 2022 |
1 |
| 2 |
34562089 | The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition. | 2022 Mar 3 |
2 |
| 3 |
34728188 | Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin. | 2022 Jan 5 |
2 |
| 4 |
34783124 | Ginsenoside RG1 augments doxorubicin-induced apoptotic cell death in MDA-MB-231 breast cancer cell lines. | 2022 Jan |
1 |
| 5 |
34871862 | miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux. | 2022 Jan |
2 |
| 6 |
34903608 | Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression. | 2022 Feb 1 |
1 |
| 7 |
35053211 | Cancer-Related Intracellular Signalling Pathways Activated by DOXorubicin/Cyclodextrin-Graphene-Based Nanomaterials. | 2022 Jan 1 |
1 |
| 8 |
35053325 | Transient Exposure of Endothelial Cells to Doxorubicin Leads to Long-Lasting Vascular Endothelial Growth Factor Receptor 2 Downregulation. | 2022 Jan 8 |
1 |
| 9 |
35078992 | Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response. | 2022 Jan 25 |
1 |
| 10 |
35202675 | Suppression of the doxorubicin response by hypoxia-inducible factor-1α is strictly dependent on oxygen concentrations under hypoxic conditions. | 2022 Apr 5 |
1 |
| 11 |
35223843 | Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy. | 2022 |
1 |
| 12 |
35311459 | Compound cellular stress maximizes apoptosis independently of p53 in glioblastoma. | 2022 Jun |
3 |
| 13 |
35419287 | Propofol Inhibits Proliferation and Augments the Anti-Tumor Effect of Doxorubicin and Paclitaxel Partly Through Promoting Ferroptosis in Triple-Negative Breast Cancer Cells. | 2022 |
1 |
| 14 |
35421634 | BAK plays a key role in A-1331852-induced apoptosis in senescent chondrocytes. | 2022 Jun 18 |
1 |
| 15 |
35511749 | A high-throughput screening platform identifies novel combination treatments for Malignant Peripheral Nerve Sheath Tumors. | 2022 May 5 |
1 |
| 16 |
35551917 | Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation. | 2022 Jul |
1 |
| 17 |
33528639 | Correction to: Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways. | 2021 Nov |
1 |
| 18 |
33591455 | Differential sensitivity of renal carcinoma cells to doxorubicin and epigenetic therapeutics depends on the genetic background. | 2021 Jun |
2 |
| 19 |
33738256 | Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer. | 2021 |
1 |
| 20 |
33767588 | miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy. | 2021 |
3 |
| 21 |
33915913 | Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines. | 2021 Apr 1 |
2 |
| 22 |
33925586 | Chromatin-Directed Proteomics Identifies ZNF84 as a p53-Independent Regulator of p21 in Genotoxic Stress Response. | 2021 Apr 27 |
1 |
| 23 |
34122059 | Doxorubicin/Nucleophosmin Binding Protein-Conjugated Nanoparticle Enhances Anti-leukemia Activity in Acute Lymphoblastic Leukemia Cells in vitro and in vivo. | 2021 |
1 |
| 24 |
34315513 | Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases. | 2021 Jul 27 |
1 |
| 25 |
34365455 | Engineered Aging Cardiac Tissue Chip Model for Studying Cardiovascular Disease. | 2021 Aug 6 |
1 |
| 26 |
34395436 | Integrated Chromatin Accessibility and Transcriptome Landscapes of Doxorubicin-Resistant Breast Cancer Cells. | 2021 |
1 |
| 27 |
34504568 | Role of C5a and C5aR in doxorubicin-induced cardiomyocyte senescence. | 2021 Oct |
1 |
| 28 |
34681897 | Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell. | 2021 Oct 18 |
2 |
| 29 |
34912912 | Evaluation of cytotoxicity and anticancer activity of kombucha and doxorubicin combination therapy on colorectal cancer cell line HCT-116. | 2021 |
1 |
| 30 |
34948101 | Poly(C)-binding Protein 2 Regulates the p53 Expression via Interactions with the 5'-Terminal Region of p53 mRNA. | 2021 Dec 10 |
1 |
| 31 |
31073076 | Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia. | 2020 Jan |
1 |
| 32 |
31841768 | Towards the overcoming of anticancer drug resistance mediated by p53 mutations. | 2020 Mar |
1 |
| 33 |
31892970 | Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells. | 2020 |
2 |
| 34 |
31923941 | A stimuli-responsive combination therapy for recovering p53-inactivation associated drug resistance. | 2020 Mar |
4 |
| 35 |
32054357 | Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone. | 2020 Jan-Dec |
2 |
| 36 |
32093041 | BTG4 is A Novel p53 Target Gene That Inhibits Cell Growth and Induces Apoptosis. | 2020 Feb 19 |
1 |
| 37 |
32297602 | Sensitive and selective monitoring of the DNA damage-induced intracellular p21 protein and unraveling the role of the p21 protein in DNA repair and cell apoptosis by surface plasmon resonance. | 2020 May 21 |
2 |
| 38 |
32330121 | Mitochondrial nucleoid remodeling and biogenesis are regulated by the p53-p21WAF1-PKCζ pathway in p16INK4a-silenced cells. | 2020 Apr 24 |
1 |
| 39 |
32391420 | Protective role of p53 in doxorubicin-induced cardiomyopathy as a mitochondrial disease. | 2020 |
5 |
| 40 |
32478947 | Cell cycle arrest and apoptosis are not dependent on p53 prior to p53-dependent embryonic stem cell differentiation. | 2020 Sep |
2 |
| 41 |
32505665 | Doxorubicin chemotherapy-induced "chemo-brain": Meta-analysis. | 2020 Aug 15 |
1 |
| 42 |
32528731 | Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells. | 2020 |
4 |
| 43 |
32712543 | The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes. | 2020 Oct |
1 |
| 44 |
32825184 | HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3. | 2020 Aug 19 |
3 |
| 45 |
32919690 | Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapy. | 2020 Dec |
1 |
| 46 |
32960902 | Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts. | 2020 |
3 |
| 47 |
33001126 | Fabrication of aminated poly(glycidyl methacrylate)-based polymers for co-delivery of anticancer drugs and the p53 gene. | 2020 Oct 28 |
8 |
| 48 |
33091670 | Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity. | 2020 Dec |
1 |
| 49 |
33121131 | O-GlcNAc Transferase Inhibitor Synergistically Enhances Doxorubicin-Induced Apoptosis in HepG2 Cells. | 2020 Oct 27 |
1 |
| 50 |
33137557 | Design and synthesis of new pyranoquinolinone heteroannulated to triazolopyrimidine of potential apoptotic antiproliferative activity. | 2020 Dec |
1 |